Recursion Pharmaceuticals (RXRX) Selling, General & Administrative (2020 - 2026)
Recursion Pharmaceuticals (RXRX) reported Selling, General & Administrative of $41.53 million for Q2 2026, down 11.0% from $46.65 million a year earlier but up 20.1% from the prior quarter.
Recursion Pharmaceuticals (RXRX) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Recursion Pharmaceuticals' Selling, General & Administrative came in at $151.41 million, down 30.0% year-over-year; for FY2025, it came in at $176.59 million, down 0.9% from FY2024.
- Selling, General & Administrative has a five-year compound annual growth rate of 47.5% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $178.18 million in FY2024 (+60.8%), $110.82 million in FY2023 (+35.8%), $81.6 million in FY2022 (+41.5%) and $57.68 million in FY2021 (+128.4%).
- Five-year quarterly Selling, General & Administrative spans a low of $15.69 million in Q3 2021 and a high of $77.19 million in Q4 2024.
- Year over year, Selling, General & Administrative has now declined in each of the last three quarters, with growth averaging 26.2% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q4 2021 (growth of 153.5%); the low point was Q4 2025 (a decline of 56.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $34.59 million (Q1 2026), $33.66 million (Q4 2025) and $41.63 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Recursion Pharmaceuticals | 2.17 Bn | -429.42 Mn | -3.82 Mn | 41.53 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.53 Mn |
| Mar 31, 2026 | 34.59 Mn |
| Dec 31, 2025 | 33.66 Mn |
| Sep 30, 2025 | 41.63 Mn |
| Jun 30, 2025 | 46.65 Mn |
| Mar 31, 2025 | 54.65 Mn |
| Dec 31, 2024 | 77.19 Mn |
| Sep 30, 2024 | 37.76 Mn |
| Jun 30, 2024 | 31.83 Mn |
| Mar 31, 2024 | 31.41 Mn |
| Dec 31, 2023 | 30.46 Mn |
| Sep 30, 2023 | 29.20 Mn |
| Jun 30, 2023 | 28.29 Mn |
| Mar 31, 2023 | 22.87 Mn |
| Dec 31, 2022 | 19.84 Mn |
| Sep 30, 2022 | 19.49 Mn |
| Jun 30, 2022 | 21.20 Mn |
| Mar 31, 2022 | 21.07 Mn |
| Dec 31, 2021 | 19.20 Mn |
| Sep 30, 2021 | 15.69 Mn |
Recursion Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();